Dr. Hönle AG reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported sales was EUR 24.34 million compared to EUR 25.91 million a year ago. Net income was EUR 0.181 million compared to EUR 0.68 million a year ago.
For the six months, sales was EUR 48.12 million compared to EUR 53.53 million a year ago. Net loss was EUR 0.729 million compared to net income of EUR 2.6 million a year ago. Basic loss per share from continuing operations was EUR 0.13 compared to basic earnings per share from continuing operations of EUR 0.37 a year ago. Diluted loss per share from continuing operations was EUR 0.13 compared to diluted earnings per share from continuing operations of EUR 0.37 a year ago.